Iovance Biotherapeutics (IOVA) Tops Q1 EPS by 7c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Citi raises Micron Technology price target to $1,300
• Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform